{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Eloralintide", "query": { "intervention": "Eloralintide" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 14, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Eloralintide&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T22:02:41.200Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07701083", "title": "A Study of Eloralintide (LY3841136) in Healthy Participants", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Eloralintide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 58, "start_date": "2026-07-20", "completion_date": "2026-10", "has_results": false, "last_update_posted_date": "2026-08-20", "last_synced_at": "2026-09-03T22:02:41.200Z", "location_count": 2, "location_summary": "Daytona Beach, Florida • Dallas, Texas", "locations": [ { "city": "Daytona Beach", "state": "Florida" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07701083" }, { "nct_id": "NCT07369011", "title": "A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Sleep Apnea, Obstructive", "Obesity", "Overweight" ], "interventions": [ { "name": "Eloralintide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 800, "start_date": "2026-02-10", "completion_date": "2028-04", "has_results": false, "last_update_posted_date": "2026-08-24", "last_synced_at": "2026-09-03T22:02:41.200Z", "location_count": 23, "location_summary": "Cullman, Alabama • Long Beach, California • Los Alamitos, California + 19 more", "locations": [ { "city": "Cullman", "state": "Alabama" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT07369011" }, { "nct_id": "NCT06916065", "title": "A Study of Eloralintide (LY3841136) and Eloralintide With Tirzepatide in Participants With Overweight or Obesity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Overweight", "Obesity" ], "interventions": [ { "name": "Eloralintide and Tirzepatide", "type": "DRUG" }, { "name": "Eloralintide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 188, "start_date": "2025-04-09", "completion_date": "2026-01-19", "has_results": false, "last_update_posted_date": "2026-01-30", "last_synced_at": "2026-09-03T22:02:41.200Z", "location_count": 3, "location_summary": "Anaheim, California • Daytona Beach, Florida • Dallas, Texas", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Daytona Beach", "state": "Florida" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06916065" }, { "nct_id": "NCT07738614", "title": "A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Obesity", "Overweight" ], "interventions": [ { "name": "Eloralintide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 56, "start_date": "2026-07-31", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-08-20", "last_synced_at": "2026-09-03T22:02:41.200Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07738614" }, { "nct_id": "NCT06143956", "title": "A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Obesity", "Overweight" ], "interventions": [ { "name": "LY3305677", "type": "DRUG" }, { "name": "LY3841136", "type": "DRUG" }, { "name": "Tirzepatide", "type": "DRUG" }, { "name": "LY3549492", "type": "DRUG" }, { "name": "LY3532226", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 1481, "start_date": "2023-11-17", "completion_date": "2028-02", "has_results": false, "last_update_posted_date": "2026-08-06", "last_synced_at": "2026-09-03T22:02:41.200Z", "location_count": 49, "location_summary": "Chandler, Arizona • Phoenix, Arizona • Scottsdale, Arizona + 44 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Greenbrae", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06143956" }, { "nct_id": "NCT07589608", "title": "A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Overweight", "Obesity" ], "interventions": [ { "name": "Macupatide", "type": "DRUG" }, { "name": "Eloralintide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 400, "start_date": "2026-05-15", "completion_date": "2028-02", "has_results": false, "last_update_posted_date": "2026-08-06", "last_synced_at": "2026-09-03T22:02:41.200Z", "location_count": 40, "location_summary": "Chandler, Arizona • Scottsdale, Arizona • Tucson, Arizona + 37 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Greenbrae", "state": "California" }, { "city": "Huntington Park", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07589608" }, { "nct_id": "NCT07426380", "title": "A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Kidney Disease", "Renal Insufficiency Chronic", "Kidney Failure, Chronic", "Renal Impairment", "Renal Insufficiency", "End Stage Kidney Disease" ], "interventions": [ { "name": "LY3841136", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 28, "start_date": "2026-02-24", "completion_date": "2026-10", "has_results": false, "last_update_posted_date": "2026-08-19", "last_synced_at": "2026-09-03T22:02:41.200Z", "location_count": 2, "location_summary": "Miami Lakes, Florida • Orlando, Florida", "locations": [ { "city": "Miami Lakes", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT07426380" }, { "nct_id": "NCT07321886", "title": "A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Obesity", "Overweight" ], "interventions": [ { "name": "Eloralintide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1980, "start_date": "2026-02-06", "completion_date": "2030-07", "has_results": false, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-09-03T22:02:41.200Z", "location_count": 41, "location_summary": "Tuscaloosa, Alabama • Scottsdale, Arizona • Escondido, California + 37 more", "locations": [ { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Escondido", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Palm Springs", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07321886" }, { "nct_id": "NCT07215559", "title": "A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Obesity", "Overweight", "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Macupatide", "type": "DRUG" }, { "name": "Eloralintide", "type": "DRUG" }, { "name": "Macupatide Placebo", "type": "DRUG" }, { "name": "Eloralintide Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 200, "start_date": "2025-10-16", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-09-03T22:02:41.200Z", "location_count": 26, "location_summary": "Gilbert, Arizona • Phoenix, Arizona • Tucson, Arizona + 20 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Sunrise", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07215559" }, { "nct_id": "NCT07282600", "title": "A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Overweight", "Obesity" ], "interventions": [ { "name": "Eloralintide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1035, "start_date": "2025-12-15", "completion_date": "2028-02", "has_results": false, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-09-03T22:02:41.200Z", "location_count": 60, "location_summary": "Birmingham, Alabama • Cullman, Alabama • Tucson, Arizona + 56 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Cullman", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Canoga Park", "state": "California" }, { "city": "Escondido", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07282600" } ] }